Chronic kidney disease (CKD) is caused by structural or functional abnormalities in the kidney that impair its ability to filter blood. The CKD drug market primarily comprises antihypertensive…
Chronic kidney disease (CKD) refers to a set of heterogenous disorders that affect the structure and function of the kidneys. The CKD drug market comprises a wide variety of antihypertensive…
Chronic kidney disease (CKD) refers to a set of heterogenous disorders that affect the structure and function of the kidneys. The CKD drug market comprises a wide variety of antihypertensive agents…
Updated report will appear soon
Because of the lack of disease-modifying agents for CKD, treatment is aimed at minimizing the symptoms and complications arising from progressively diminished kidney function and treating the…
Clarivate Epidemiology’s coverage of CKD comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the total prevalence of CKD for each country, as well…
Chronic kidney disease (CKD) is a general term for a set of heterogeneous disorders that negatively affect the function and structure of the kidney. CKD is characterized by a progressive loss of…
The total number of prevalent cases of CKD across the countries under study will increase by 20% from 343 million in 2016 to 411 million in 2026. Of the 1.5 million people with stage 5 CKD,…
The total number of prevalent cases of CKD across the countries under study will increase by 24% from 17.8 million in 2016 to 22 million in 2026. Of the 153,000 people with stage 5 CKD,…
The total number of prevalent cases of CKD across the Asia-Pacific countries under study will increase by 25% from 51 million in 2016 to 64 million in 2026. Of the 460,000 people with stage 5…
The total number of prevalent cases of CKD across the European countries under study will increase by 11% from 14.4 million in 2016 to 16 million in 2026. Of the 191,000 people with stage 5 CKD…
The total number of prevalent cases of CKD across the countries under study will increase by 29% from 24 million in 2016 to 31 million in 2026. Of the 62.2 thousand people with stage 5 CKD,…
The United States has seen a dramatic rise in the prevalence of chronic kidney disease (CKD) and its sequelae—namely, diabetes and hypertension. Patients with CKD are typically co-managed by many…
Chronic kidney disease (CKD) is a general term for a set of heterogeneous disorders that negatively affect the function and structure of the kidney. It is characterized by a progressive loss of…
This report leverages physician insights, as well as patient chart data, to provide the most up-to-date information about chronic kidney disease non-dialysis (CKD-ND) patient care in France,…